Modular Medical Toekomstige groei

Future criteriumcontroles 2/6

De verwachting is dat Modular Medical de winst en omzet met respectievelijk 28% en 196.4% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 36.8% per jaar.

Belangrijke informatie

28.0%

Groei van de winst

36.8%

Groei van de winst per aandeel

Medical Equipment winstgroei	17.1%
Inkomstengroei	196.4%
Toekomstig rendement op eigen vermogen	n/a
Dekking van analisten	Low
Laatst bijgewerkt	05 Sep 2024

Recente toekomstige groei-updates

Recent updates

Here's Why Modular Medical (NASDAQ:MODD) Must Use Its Cash Wisely

Jul 16

Here's Why We're A Bit Worried About Modular Medical's (NASDAQ:MODD) Cash Burn Situation

Oct 08

Winst- en omzetgroeiprognoses

NasdaqCM:MODD - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
3/31/2026	9	-12	N/A	-6	1
3/31/2025	1	-16	N/A	-11	1
9/30/2024	N/A	-19	-17	-15	N/A
6/30/2024	N/A	-18	-16	-14	N/A
3/31/2024	N/A	-17	-16	-14	N/A
12/31/2023	N/A	-17	-16	-13	N/A
9/30/2023	N/A	-15	-14	-12	N/A
6/30/2023	N/A	-14	-13	-12	N/A
3/31/2023	N/A	-14	-13	-11	N/A
12/31/2022	N/A	-15	-12	-11	N/A
9/30/2022	N/A	-16	-11	-11	N/A
6/30/2022	N/A	-17	-11	-11	N/A
3/31/2022	N/A	-19	-10	-10	N/A
12/31/2021	N/A	-16	-8	-8	N/A
9/30/2021	N/A	-13	-8	-8	N/A
6/30/2021	N/A	-10	-7	-7	N/A
3/31/2021	N/A	-7	-6	-6	N/A
12/31/2020	N/A	-8	-6	-6	N/A
9/30/2020	N/A	-7	-6	-5	N/A
6/30/2020	N/A	-6	-5	-5	N/A
3/31/2020	N/A	-5	-4	-4	N/A
12/31/2019	N/A	-4	-4	-3	N/A
9/30/2019	N/A	-4	-3	-3	N/A
6/30/2019	N/A	-3	-2	-2	N/A
3/31/2019	N/A	-3	-2	-2	N/A
12/31/2018	N/A	-2	-1	-1	N/A
9/30/2018	N/A	-1	-1	-1	N/A
6/30/2018	N/A	-1	N/A	-1	N/A
3/31/2018	N/A	-1	N/A	-1	N/A
12/31/2017	N/A	0	N/A	-1	N/A
9/30/2017	N/A	0	N/A	0	N/A
6/30/2017	N/A	0	N/A	0	N/A
3/31/2017	N/A	0	N/A	0	N/A
12/31/2016	N/A	0	N/A	N/A	N/A
9/30/2016	N/A	0	N/A	N/A	N/A
6/30/2016	N/A	0	N/A	0	N/A
3/31/2016	N/A	0	N/A	N/A	N/A
12/31/2015	N/A	0	N/A	N/A	N/A
9/30/2015	N/A	0	N/A	N/A	N/A
6/30/2015	N/A	0	N/A	N/A	N/A
3/31/2015	N/A	0	N/A	N/A	N/A
12/31/2014	N/A	0	N/A	N/A	N/A
9/30/2014	N/A	0	N/A	N/A	N/A
6/30/2014	N/A	0	N/A	N/A	N/A
3/31/2014	N/A	0	N/A	N/A	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachting is dat MODD de komende 3 jaar verliesgevend zal blijven.

Winst versus markt: De verwachting is dat MODD de komende 3 jaar verliesgevend zal blijven.

Hoge groeiwinsten: De verwachting is dat MODD de komende 3 jaar verliesgevend zal blijven.

Omzet versus markt: De omzet van MODD ( 196.4% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.9% per jaar).

Hoge groei-inkomsten: De omzet van MODD ( 196.4% per jaar) zal naar verwachting sneller groeien dan 20% per jaar.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van MODD naar verwachting over 3 jaar hoog zal zijn

Modular Medical Toekomstige groei

Future criteriumcontroles 2/6

Belangrijke informatie

Recente toekomstige groei-updates

Consensus revenue estimates decrease by 40%, EPS upgraded

Recent updates

Modular Medical, Inc. has filed a Follow-on Equity Offering.

Modular Medical, Inc. Announces Results from a Successful GLP-1 Proof of Concept Study

Modular Medical, Inc. Announces Finalization of Protocol for GLP-1 Personalized Metabolic Therapy Study Utilizing the Modd1 Platform

Modular Medical, Inc Announces FDA Clearance of the MODD1 Insulin Pump

Consensus revenue estimates decrease by 40%, EPS upgraded

Here's Why Modular Medical (NASDAQ:MODD) Must Use Its Cash Wisely

New major risk - Financial position

New major risk - Share price stability

Modular Medical, Inc. has completed a Follow-on Equity Offering in the amount of $10.000001 million.

New major risk - Financial position

Modular Medical, Inc., Annual General Meeting, Feb 13, 2024

Modular Medical, Inc. has filed a Follow-on Equity Offering in the amount of $6.5 million.

Modular Medical, Inc. has filed a Follow-on Equity Offering in the amount of $6.5 million.

Modular Medical, Inc. Updates Test Progress and Submission Timeline

Here's Why We're A Bit Worried About Modular Medical's (NASDAQ:MODD) Cash Burn Situation

Director recently bought US$156k worth of stock

Modular Medical, Inc. Announces Appointment of Duane DeSisto to its Board of Directors

New major risk - Share price stability

Modular Medical, Inc. has completed a Composite Units Offering in the amount of $9.389999 million.

Modular Medical, Inc. has completed a Composite Units Offering in the amount of $9.4 million.

Modular Medical (NASDAQ:MODD) Will Have To Spend Its Cash Wisely

Modular Medical, Inc. Provides Update on FDA Submission Strategy

Modular Medical, Inc., Annual General Meeting, Jan 17, 2023

Modular Medical, Inc. Announces Update on Development of its Initial Insulin Pump Product

We're Keeping An Eye On Modular Medical's (NASDAQ:MODD) Cash Burn Rate

High number of new directors

Modular Medical Provides Product Update

Modular Medical, Inc. Appoints Kevin Schmid as Chief Operating Officer

Modular Medical appoints Kevin Schmid as COO

We Think Modular Medical (NASDAQ:MODD) Needs To Drive Business Growth Carefully

High number of new directors

Modular Medical: Next Generation Insulin Pump Developer

Modular Medical, Inc. Announces Executive Changes

Manchester Management Engages in Discussions with Modular Medical

Modular Medical Common Stock Deleted from Other OTC

High number of new directors

Modular Medical, Inc. announced that it has received $6.56 million in funding

Modular Medical, Inc. announced that it has received $1.1 million in funding

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven